Tsuneaki Hirakawa

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia

Satoshi Wakita, Hiroki Yamaguchi, Ikuko Omori et al. · Leukemia · 2012 · 88 citations

Medicine, Hematology, Molecular Genetics +13

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

Tsuneaki Hirakawa, Hiroki Yamaguchi, Norio Yokose et al. · Annals of Hematology · 2010 · 86 citations

Medicine, Hematology, Oncology +8

Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia

Satoshi Wakita, Hiroki Yamaguchi, Tomoyuki Ueki et al. · Leukemia · 2015 · 57 citations

Life Sciences, Genetics, Molecular Genetics +15

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease

Yayoi Matsumura‐Kimoto, Yoshihiro Inamoto, Kinuko Tajima et al. · Biology of Blood and Marrow Transplantation · 2016 · 51 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies

Masahiro Sakaguchi, Kazutaka Nakayama, Hiroki Yamaguchi et al. · Acta Haematologica · 2019 · 28 citations

Medicine, Hematology, Nephrology +12